456

<i>PEPTOSTREPTOCOCCUS STOMATIS</i> PROMOTES COLORECTAL TUMORIGENESIS AND TYROSINE KINASE INHIBITOR RESISTANCE THROUGH ALTERNATIVE ACTIVATION OF ERBB2

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

Background and Aims: Peptostreptococcus stomatis (P. stomatis) is an enriched bacterium in colorectal cancer (CRC) patients as compared to healthy subjects in multiple cohorts. However, the potential role of P. stomatis in colorectal tumorigenesis remains obscure. In this study, we investigate the function of P. stomatis in CRC, and its impact on CRC therapy response.

Methods: Pro-tumorigenic effect of P. stomatis on colorectal carcinogenesis was determined in ApcMin/+ mice and azoxymethane/Dextran sodium sulfate (AOM-DSS)-treated mice models. In vitro function of P. stomatis was analysed by cell proliferation, apoptosis, and cell cycle assays. Interplay between P. stomatis and CRC cells was evaluated by fluorescence in situ hybridization (FISH), scanning electron microscopy (SEM), transmission electron microscopy (TEM), adhesion and invasion assays. The interaction between P. stomatis surface protein and the receptor of CRC cells was investigated by far-western, biotin pulldown, and glutathione S-transferase (GST) pulldown assays.

Results: Oral gavage of P. stomatis significantly promoted CRC tumorigenesis in ApcMin/+ mice with increased colon tumor number and tumor load, which accompanied with enhanced cell proliferation, reduced apoptosis and impaired gut barrier function. The pro-tumorigenic effect of P. stomatis was validated in another CRC tumorigenesis model induced by AOM-DSS and in CRC cell line Caco2 formed xenograft models. Consistently, P. stomatis co-culture with CRC cells accelerated cell growth, induced G1-S cell cycle progression, and suppressed apoptosis. FISH, TEM and in vitro adhesion/invasion assays showed that P. stomatis colonized on CRC cells and colonic epithelium cells of mice, with preferential adherence in tumor cells compared to normal colon cells. Mechanistically, P. stomatis surface protein fructose-1,6-bisphosphate aldolase (FBA) binds to integrin α6/β4 receptor of CRC cells and activates ERBB2 phosphorylation, leading to the consequential activation of MEK-ERK-p90 oncogenic signaling. Integrin α6/β4 knockdown abolished P. stomatis adherence and P. stomatis-induced ERBB2-MEK-ERK-p90 activation in vitro, implying that the FBA-integrin α6/β4 interaction is essential for P. stomatis-mediated tumorigenesis. Finally, we demonstrated that P. stomatis co-culture with colon cancer cell lines Caco-2 and HT-29 significantly abolished the therapeutic effects of Cetuximab and Vemurafenib, implying P. stomatis as a novel factor driving tyrosine kinase (RTK) inhibitor resistance through alternative activation of ERBB2 in CRC.

Conclusion: P. stomatis is a novel oncogenic bacterium in promoting colorectal carcinogenesis. P. stomatis surface protein FBA engages an integrin α6/β4-ERBB2 complex leading to aberrant activation of host oncogenic MEK-ERK-p90 signaling to drive CRC development and cause resistance to RTK inhibitors.

Tracks

Related Products

Thumbnail for <i>PEPTOSTREPTOCOCCUS ANEROBIUS </i>DIVES IMMUNE THERAPY RESISTANCE THROUGH MODULATING MDSCS IN COLORECTAL CANCER
<i>PEPTOSTREPTOCOCCUS ANEROBIUS </i>DIVES IMMUNE THERAPY RESISTANCE THROUGH MODULATING MDSCS IN COLORECTAL CANCER
BACKGROUND AND AIMS: Peptostreptococcus stomatis (_P. stomatis_) is an enriched bacterium in colorectal cancer (CRC) patients as compared to healthy subjects in multiple cohorts. However, the potential role of _P. stomatis_ in colorectal tumorigenesis remains obscure…
Thumbnail for IMMUNE EVASION OF COLORECTAL CANCER STEM CELLS IS DEPENDENT ON SLC25A22-MEDIATED WNT SIGNALING
IMMUNE EVASION OF COLORECTAL CANCER STEM CELLS IS DEPENDENT ON SLC25A22-MEDIATED WNT SIGNALING
Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
Thumbnail for <i>ROSEBURIA INTESTINALIS </i>GENERATED BUTYRATE BOOSTS ANTI-PD-1 EFFICACY IN COLORECTAL CANCER BY ACTIVATING CYTOTOXIC CD8<sup>+</sup> T CELLS
<i>ROSEBURIA INTESTINALIS </i>GENERATED BUTYRATE BOOSTS ANTI-PD-1 EFFICACY IN COLORECTAL CANCER BY ACTIVATING CYTOTOXIC CD8<sup>+</sup> T CELLS
BACKGROUND: Emerging evidence suggest that gut microbiota influence human health such as digestive functions and risk of sepsis…
Thumbnail for RNA N<sup>6</sup>-METHYLADENOSINE READER YTHDF1 PROMOTES STEMNESS AND DRUG RESISTANCE OF COLORECTAL CANCER THROUGH INDUCING NOTCH1 AND IS A THERAPEUTIC TARGET
RNA N<sup>6</sup>-METHYLADENOSINE READER YTHDF1 PROMOTES STEMNESS AND DRUG RESISTANCE OF COLORECTAL CANCER THROUGH INDUCING NOTCH1 AND IS A THERAPEUTIC TARGET
BACKGROUND: Immune checkpoint blockade has revolutionized cancer treatment by harnessing the patient’s native anti-tumor T cells, but most colorectal cancers do not respond, for unclear reasons…